Imugene has received a Notice of Grant from the European Patent Office for Patent Application 10744895.3, which protects the company's HER-Vaxx cancer immunotherapy. [ + ]

Associate Professor Chamindie Punyadeera is looking to produce a heart failure test that is quick and easy to administer, by screening saliva instead of blood. [ + ]

The projected rate of return on pharmaceutical R&D has more than halved since 2010, from 10.1% to 4.2%, according to an annual study by the Deloitte Centre for Health Solutions. [ + ]

The Australian Research Council has announced $38.6 million of funding to support 50 new research projects as part of the Future Fellowships initiative. [ + ]

Pharmaxis has announced positive results for its recently completed Phase II trial of Bronchitol, a precision spray-dried form of mannitol, in children and adolescents with cystic fibrosis (CF). [ + ]

Researchers have discovered that tissue-resident memory T cells — specialised immune cells that live in tissues such as the skin and lung — play an important role in protecting against infection. [ + ]

GSK Australia's new pilot facility will use an innovative manufacturing method to produce vaccines on a commercial scale. [ + ]

The boards of DuPont and The Dow Chemical Company have unanimously approved a definitive agreement under which the companies will combine in an all-stock merger of equals. [ + ]

The CSIRO and chemical manufacturer Boron Molecular have signed a technology transfer agreement which is set to accelerate the commercialisation of a range of Australian technologies. [ + ]

A University of Melbourne research team will use a US$200,000 grant from the Bill & Melinda Gates Foundation to develop a one-shot vaccine for Taenia solium. [ + ]

A new endowment fund will bring science students and academics from the developing world to study and do research at the Australian National University (ANU). [ + ]

The inaugural inspiring women fellowships have provided four Australian female researchers with the support they need to juggle career and carer commitments and remain competitive in their fields of endeavour. [ + ]

Architect Janjaap Ruijssenaars has developed a method to generate free energy in a sustainable way. The patent-pending technique, which sees energy released by perpetually unbalancing a weight, offers an alternative to solar and wind technology. [ + ]

'State of Australian University Research 2015–16' presents the outcomes of the Excellence in Research for Australia 2015 evaluations and details the quality of Australian university research benchmarked against world standards. [ + ]

The Centre for Therapeutic Target Validation has launched the Target Validation Platform — a web-based platform that helps life science researchers identify therapeutic targets for new and repurposed medicines. [ + ]